Literature DB >> 11491021

Diverse biological activities of moxa extract and smoke.

N Hitosugi1, R Ohno, I Hatsukari, S Mizukami, H Nagasaka, I Matsumoto, N Komatsu, M Fujimaki, H Nakashima, K Satoh, H Sakagami.   

Abstract

Diverse biological activities of moxa extracts and smoke (gas phase) were investigated. Moxa was extracted with hot water (Fr. I), or ethanol (Fr. II), or extracted with hot water after ethanol wash (Fr. III) and then lyophilized to obtain the dried powders. Moxa smoke (containing a lot of gaseous components obtained by burning Moxa) (Fr. IV) was collected into phosphate-buffered saline and quantified spectrophotometrically. These extracts and Moxa smoke showed comparable cytotoxic activity against human oral tumor cell lines (HSC-2, HSG). Human gingival fibroblasts (HGF) were more resistant to any Moxa fractions. Neither of the extracts showed anti-HIV activity. Pretreatment of mice with Fr. I significantly reduced the lethal effect of E. coli infection. All extracts produced radicals under alkaline condition, with a maximum intensity at pH 10.5, and enhanced the radical intensity of sodium ascorbate. It was unexpected that these extracts show significant O2- scavenging activities. These data suggest the medicinal efficacy of Moxa extracts and smoke.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11491021

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  10 in total

1.  The Case for Moxibustion for Painful Syndromes: History, principles and rationale.

Authors:  Nigel C Dawes; Joyce K Anastasi
Journal:  Curr Res Compliment Altern Med       Date:  2022-02-23

Review 2.  The mechanism of moxibustion: ancient theory and modern research.

Authors:  Hongyong Deng; Xueyong Shen
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-12       Impact factor: 2.629

3.  The effect of different laser irradiation on cyclophosphamide-induced leucopenia in rats.

Authors:  Jizhong Zhao; Ke Cheng; Haiping Deng; Ling Zhao; Lanlan Liu; Menghu Guo; Haimeng Zhang; Xueyong Shen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-14       Impact factor: 2.629

4.  Bibliometric Analysis of Moxibustion Research Trends over the Past 20 Years.

Authors:  Hyejin Park; In-Seon Lee; Hyangsook Lee; Younbyoung Chae
Journal:  J Clin Med       Date:  2020-04-26       Impact factor: 4.241

5.  Comparison of the Efficacy between Conventional Moxibustion and Smoke-Free Moxibustion on Knee Osteoarthritis: A Randomized Controlled Trial.

Authors:  Ling Luo; Mo Liao; Jia-Xi Peng; Qi Ma; Jian-Ying Zhou; Lin-Lin Zhu; Xiang Wang; Sha-Sha Chen; Hai-Yan Yin; Qiao-Feng Wu; Cheng-Shun Zhang; Peng Lv; Yong Tang; Shu-Guang Yu
Journal:  Evid Based Complement Alternat Med       Date:  2019-03-14       Impact factor: 2.629

6.  Effects of Moxa Smoke on Monoamine Neurotransmitters in SAMP8 Mice.

Authors:  Huanfang Xu; Baixiao Zhao; Yingxue Cui; Min Yee Lim; Ping Liu; Li Han; Hongzhu Guo; Lixing Lao
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-13       Impact factor: 2.629

Review 7.  Effectiveness of Stimulation of Acupoint KI 1 by Artemisia vulgaris (Moxa) for the Treatment of Essential Hypertension: A Systematic Review of Randomized Controlled Trials.

Authors:  Xiaochen Yang; Xingjiang Xiong; Guoyan Yang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-13       Impact factor: 2.629

Review 8.  Safety of moxibustion: a systematic review of case reports.

Authors:  Ji Xu; Hongyong Deng; Xueyong Shen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-26       Impact factor: 2.629

9.  Comparison of the efficacy between conventional moxibustion and smoke-free moxibustion on knee osteoarthritis: study protocol of a randomized controlled trial.

Authors:  Lin-Lin Zhu; Jian-Ying Zhou; Ling Luo; Xiang Wang; Jia-Xi Peng; Sha-Sha Chen; Hai-Yan Yin; Qiao-Feng Wu; Cheng-Shun Zhang; Peng Lv; Yong Tang; Shu-Guang Yu
Journal:  Trials       Date:  2017-04-24       Impact factor: 2.279

10.  Analysis of the Components in Moxa Smoke by GC-MS and Preliminary Discussion on Its Toxicity and Side Effects.

Authors:  Xiaoyu Xu; Si Shan; Wenlei Wang; Hongning Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-31       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.